Clinical and Experimental Pharmacology and Physiology · Published 2026-06-30 · DOI 10.1111/1440-1681.70143
Xingxing Li, Guibing He, Fen Zhang, Jie Wu, Shu Chen, Yang Dong
PubPorta does not have an abstract for this article yet.
Read the article at the publisher →
Li, X., He, G., Zhang, F., et al. (2026). Dapagliflozin Improves Mitochondrial Function to Reduce the Risk of Atrial Fibrillation in a High‐Glucose Environment by Activating the AMPK/PGC‐1α/SIRT3 Signalling Pathway. Clinical and Experimental Pharmacology and Physiology. https://doi.org/10.1111/1440-1681.70143